ISAP Researchers' Profiles
Jeffrey J. Annon, M.A.
Jeffrey J. Annon, M.A., is the Director of the Data Management Center for the UCLA Integrated Substance Abuse Programs (ISAP). Mr. Annon oversees the data capture, management, reporting, and cleaning for more than 20 ISAP projects. Prior to this, he was a part of the UCLA Methamphetamine Treatment Project, which compared treatments for methamphetamine abuse in five cities in the United States. He was also the Project Director for the UCLA LAAM project, which compared methadone and levo-alpha-acetyl methadol (LAAM) treatment of heroin addicts in Los Angeles. Mr. Annon has been with the UCLA Drug Abuse Research Center (which, with other entities, became ISAP in 1999) since 1990, working on various research projects.
Education and Training
- University of Hawaii at Manoa, B.A., 1980, Psychology
- California State University at Long Beach, M.A., 1993, Psychology
Contact Info
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Suite 200
Los Angeles, CA 90025
jannon@ucla.edu
Selected Publications
Ling, W., Amass, L., Shoptaw, S., Annon, J. Hillhouse, M., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muir, J., Buchan, B., Orr, D., Woody, G., Krejci, J. and Ziedonis, D. (2005). A multi-center randomized trial of Buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction, 100, 1090-1100.
Longshore, D., Annon, J., Anglin, M., and Rawson, R (2005). Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use. Addiction, 100, 1131-1139.
Amass, L, Ling, W., Freese, T., Reiber, C., Annon, J., Cohen, A. et al. (2004) Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. American Journal on Addictions, 13, S42-S66.
Grella, C. E., Annon, J. J., & Anglin, M. D. (2000). Drug use and risk for HIV among women arrestees in California. AIDS and Behavior, 5(4) 289-295.
Carpenter, C. L., Longshore, D., Annon, K., Annon, J. J., & Anglin, M. D. (1999). Prevalence of HIV-1 among recent arrestees in Los Angeles County: Serial cross-sectional study, 1991 to 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, in press.
Longshore, D., Annon, J., & Anglin, M. D. (1998). HIV prevalence among injection drug users in three Northern California communities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19(2), 200. (01.34)
Longshore, D., Annon, J., & Anglin, M. D. (1998). Long-Term Trends in Self-Reported HIV Risk Behavior: Injection Drug Users in Los Angeles, 1987 through 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1), 64-72.
Gil-Rivas, V., Anglin, M. D., & Annon, J. J. (1997). Patterns of drug use and criminal activities among Latino arrestees in California: Treatment and policy implications. Journal of Psychopathology and Behavioral Assessment, 19(2), 161-174.
Grella, C. E., Anglin, M. D., Wugalter, S. E., & Annon, J. J. (1997). The effectiveness of the Los Angeles enhanced methadone maintenance project: Reducing HIV risk among injection drug users. In F. M. Tims, J. A. Inciardi, B. W. Fletcher, & A. M. Horton (Eds.), The effectiveness of innovative approaches in the treatment of drug abuse (pp. 17-32). Westport, CT: Greenwood Press.
Grella, C.E., Anglin, M.D. and Annon, J.J. (1996). HIV Risk Behaviors Among Women in Methadone Maintenance Treatment. Substance Use and Misuse, 31(3), 277-301.
Grella, C.E., Annon, J.A. and Anglin, M.D. (1995). Ethnic Differences in HIV Risk Behaviors and Self-Perceptions Among Women in Methadone Maintenance Treatment. Journal of Psychoactive Drugs, 27(4), 319-343
Grella, C. E., Annon, J. J., & Anglin, M. D. (1995). Ethnic differences in HIV risk behaviors, self-perceptions, and treatment outcomes among women in methadone maintenance treatment. Journal of Psychoactive Drugs, 27(4), 421-433.
Last updated - 06/22/2007
Click here to view other profiles.